OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in Targeted Therapy Against Driver Mutations and Epigenetic Alterations in Non-Small Cell Lung Cancer
Jiajian Shi, Yuchen Chen, Chentai Peng, et al.
ONCOLOGIE (2022) Vol. 24, Iss. 4, pp. 613-648
Open Access | Times Cited: 14
Jiajian Shi, Yuchen Chen, Chentai Peng, et al.
ONCOLOGIE (2022) Vol. 24, Iss. 4, pp. 613-648
Open Access | Times Cited: 14
Showing 14 citing articles:
Single-Cell RNA Sequencing Reveals Potential for Endothelial-to-Mesenchymal Transition in Tetralogy of Fallot
Aisa Zulibiya, Jing Wen, Huiqing Yu, et al.
Congenital Heart Disease (2023) Vol. 18, Iss. 6, pp. 611-625
Open Access | Times Cited: 37
Aisa Zulibiya, Jing Wen, Huiqing Yu, et al.
Congenital Heart Disease (2023) Vol. 18, Iss. 6, pp. 611-625
Open Access | Times Cited: 37
SPC25 as a novel therapeutic and prognostic biomarker and its association with glycolysis, ferroptosis and ceRNA in lung adenocarcinoma
Xu‐Sheng Liu, Yu Zhang, Xing Ming, et al.
Aging (2024)
Open Access | Times Cited: 5
Xu‐Sheng Liu, Yu Zhang, Xing Ming, et al.
Aging (2024)
Open Access | Times Cited: 5
Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF)
Xing Ye, Zhouting Tuo, Kai Chen, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 3, pp. 503-515
Open Access | Times Cited: 5
Xing Ye, Zhouting Tuo, Kai Chen, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 3, pp. 503-515
Open Access | Times Cited: 5
Characteristics of Gene Mutations in Lung Cancer Patients in Southwest China and Analysis of Their Correlation with Clinical Features
康 牟
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 1100-1109
Closed Access
康 牟
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 1100-1109
Closed Access
Single‐cell RNA sequencing reveals the mechanism of PI3K/AKT/mTOR signaling pathway activation in lung adenocarcinoma by KRAS mutation
Long Xu, Renquan Ding, Shuxi Song, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 3
Long Xu, Renquan Ding, Shuxi Song, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 3
Exploring the metastasis-related biomarker and carcinogenic mechanism in liver cancer based on single cell technology
Qiuxiang Zheng, Cuiping Lu, Yu Lian, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27473-e27473
Open Access | Times Cited: 3
Qiuxiang Zheng, Cuiping Lu, Yu Lian, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27473-e27473
Open Access | Times Cited: 3
Applying machine learning algorithms to develop a survival prediction model for lung adenocarcinoma based on genes related to fatty acid metabolism
Dan Cong, Yanan Zhao, Wenlong Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Dan Cong, Yanan Zhao, Wenlong Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Comprehensive analysis of peroxisome proliferator-activated receptors to predict the drug resistance, immune microenvironment, and prognosis in stomach adenocarcinomas
Jia Qing, Baozhen Li, Xiulian Wang, et al.
PeerJ (2024) Vol. 12, pp. e17082-e17082
Open Access | Times Cited: 1
Jia Qing, Baozhen Li, Xiulian Wang, et al.
PeerJ (2024) Vol. 12, pp. e17082-e17082
Open Access | Times Cited: 1
Immunological role and clinical prognostic significance of P2RY6 in lung adenocarcinoma: a multi-omics studies and single-cell sequencing analysis
Hong Wu, Xuhui Dong
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Hong Wu, Xuhui Dong
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Dynamic changes in macrophage subtypes during lung cancer progression and metastasis at single-cell resolution
Jian Wang, Weiqing Wu, Jinquan Xia, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 8, pp. 4456-4471
Open Access | Times Cited: 2
Jian Wang, Weiqing Wu, Jinquan Xia, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 8, pp. 4456-4471
Open Access | Times Cited: 2
Constructing an APOBEC-related gene signature with predictive value in the overall survival and therapeutic sensitivity in lung adenocarcinoma
Yangchao Luo, Huiru Wang, Zhong Jian, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21336-e21336
Open Access | Times Cited: 2
Yangchao Luo, Huiru Wang, Zhong Jian, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21336-e21336
Open Access | Times Cited: 2
Global research trends in immunotherapy for non-small cell lung cancer patients with KRAS mutations: a bibliometric analysis
Hanyu Shen, Chunxiao Li
Frontiers in Oncology (2024) Vol. 14
Open Access
Hanyu Shen, Chunxiao Li
Frontiers in Oncology (2024) Vol. 14
Open Access
Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case Report
Markus Falk, Stefanie Schatz, Fabian Reich, et al.
Current Oncology (2023) Vol. 30, Iss. 10, pp. 8865-8871
Open Access
Markus Falk, Stefanie Schatz, Fabian Reich, et al.
Current Oncology (2023) Vol. 30, Iss. 10, pp. 8865-8871
Open Access
